US EditionFDA Approves Sonu Band for Drug-Free Treatment of Pediatric Nasal Congestion
- On June 11, 2025, the U.S. FDA authorized the Sonu Band, an AI-powered wearable designed to help children aged 12 and older manage moderate to severe nasal congestion from home.
- This approval follows the need for drug-free, noninvasive options to treat nasal congestion caused by allergic and nonallergic rhinitis in pediatric patients.
- The Sonu Band uses acoustic resonant sound waves personalized by a smartphone app that maps the sinuses and calculates optimal frequencies to relieve symptoms.
- More than four out of five patients experienced relief from nasal symptoms within 15 minutes, and Dr. Alan Greene highlighted Sonu as a promising, noninvasive treatment option.
- This expanded approval establishes Sonu as the first FDA-approved, drug-free device addressing pediatric nasal congestion, offering families a safe alternative to steroid medications.
Insights by Ground AI
Does this summary seem wrong?
40 Articles
40 Articles
All
Left
8
Center
10
Right
5
InsideNoVA.com+38 Reposted by 38 other sources
FDA Approves Sonu Band for Drug-Free Treatment of Pediatric Nasal Congestion
TUESDAY, June 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device for at-home treatment of moderate-to-severe nasal congestion in pediatric patients aged 12 and up.
FDA approves Sonu Band for drug-free treatment of pediatric nasal congestion
The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device for at-home treatment of moderate-to-severe nasal congestion in pediatric patients aged 12 and up.
Coverage Details
Total News Sources40
Leaning Left8Leaning Right5Center10Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 35%
C 43%
R 22%
Factuality
To view factuality data please Upgrade to Premium
